Avanos Medical Inc (AVNS)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents US$ in thousands 87,700 107,100 81,800 95,700 127,700 117,000 106,500 104,300 118,500 97,800 99,900 100,100 111,500 180,000 185,000 187,700 205,300 214,400 288,100 348,300
Short-term investments US$ in thousands
Total current liabilities US$ in thousands 234,600 170,700 160,500 158,500 191,000 162,300 151,100 152,900 139,200 129,200 158,300 154,600 166,300 179,400 176,000 189,400 212,500 218,100 187,000 238,400
Cash ratio 0.37 0.63 0.51 0.60 0.67 0.72 0.70 0.68 0.85 0.76 0.63 0.65 0.67 1.00 1.05 0.99 0.97 0.98 1.54 1.46

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($87,700K + $—K) ÷ $234,600K
= 0.37

The cash ratio measures a company's ability to cover its short-term liabilities using its cash and cash equivalents. A higher cash ratio indicates a company has more cash on hand relative to its short-term obligations.

Looking at the trend of Avanos Medical Inc's cash ratio over the past eight quarters, we observe some fluctuations. In Q4 2023, the cash ratio decreased to 0.50 compared to the previous quarter's 0.71. This could indicate a reduction in the company's cash reserves relative to its short-term liabilities.

However, the company's cash ratio has ranged between 0.50 to 0.81 over the past eight quarters, suggesting some stability in its ability to meet short-term obligations with cash. It is worth noting that the cash ratio was at its lowest point in Q4 2023 compared to the previous quarters, which may warrant further investigation into the company's cash management practices and liquidity position.

Overall, while the cash ratio provides insight into Avanos Medical Inc's short-term solvency and liquidity, additional analysis of the company's cash management and overall financial health would provide a more comprehensive understanding of its financial position.


Peer comparison

Dec 31, 2023